Martin E. Blackstein

Author

Also Known As

B. Dickson, Blackstein, M E, M Blackstein, M E Blackstein, M L Sautter-Bihl, M. Blackstein, M. E. BLACKSTEIN, M. E. Blackstein, M.E. Blackstein, MARTIN E. BLACKSTEIN

131

Publications

10.4K

Citations

H-Index

Concepts

All Affiliations

Mount Sinai Hospital University of Toronto Princess Margaret Cancer Centre Dana-Farber Cancer Institute Fox Chase Cancer Center

About

Martin E. Blackstein is an author at Mount Sinai Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	39	7.4K
2	Health Sciences	14	14	789
3	Biochemistry	3	3	113
4	Natural Sciences	2	2	66
5	Cell Biology	1	1	17

Martin E. Blackstein

Publications

10K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial George D. Demetri, Allan T. van Oosterom, Christopher R. Garrett, The Lancet Gastrointestinal OncologyMedicinePathologyColorectal CancerCancer Treatment	2006	2.6K
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial George D. Demetri, Peter Reichardt, Yoon‐Koo Kang, The Lancet Gastrointestinal OncologyMedicinePharmacologyPathologyPharmacotherapy	2012	1.4K
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu, The Lancet Surgical OncologyGastrointestinal OncologyMedicineGastroenterologyAdjuvant Imatinib Mesylate	2009	1.3K
neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. Irene L. Andrulis, Shelley B. Bull, Martin E. Blackstein, Journal of Clinical Oncology	1998	446
Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial Christopher L. Corless, Karla V. Ballman, Cristina R. Antonescu, Journal of Clinical Oncology	2014	312
Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases Anthony M. Griffin, Melania Pintilie, Martin E. Blackstein Annals of Oncology Lung MetastasesMedicineBronchial NeoplasmOncologyRadiation Oncology	2009	244
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial. Ronald L. Burkes, Robert J. Ginsberg, Frances A. Shepherd, Journal of Clinical Oncology	1992	192
Lymph Node Metastasis in Soft Tissue Sarcoma in an Extremity Soha Riad, Anthony M. Griffin, Boaz Liberman, Clinical Orthopaedics and Related Research Lymphoid NeoplasiaSurgical OncologySoft Tissue SarcomaMalignant DiseaseMedicine	2004	167
Histologic assessment of peritumoral edema in soft tissue sarcoma Lawrence M. White, Jay S. Wunder, Robert S. Bell, International Journal of Radiation OncologyBiologyPhysics Soft Tissue SarcomaSurgical PathologyHistopathologyDermatologyMedicine	2005	165
Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial Martin E. Blackstein, C. L. Vogel, Roy M. Ambinder, Oncology	2002	160

Page 1